Clinical Trial

KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome

Name: KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome — clinical trial record (NCT06588491)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Subjects with Treatment Refractory Stiff Person Syndrome

Protocol Amendment History 2 changes

critical Trial completed 2026-07-25

minor Completion moved earlier: 2026-12 -> 2026-06-25 2026-07-25

Trial Details

NCT Number	NCT06588491
Lead Sponsor	Kyverna Therapeutics
Conditions	Stiff-Person Syndrome, SPS
Enrollment	27 participants
Start Date	2024-09-25
Primary Completion	2026-06-25 (estimated)
Study Completion	2026-06-25 (estimated)
Updated on ClinicalTrials.gov	2026-07-24